Status:
WITHDRAWN
HLA-B35 Alleles and AIDS
Lead Sponsor:
National Cancer Institute (NCI)
Conditions:
HIV-1
AIDS
Eligibility:
All Genders
21+ years
Brief Summary
This study will identify variations in the genome of the human immunodeficiency virus (HIV) early after infection and following the development of AIDS. It will analyze genetic material and clinical d...
Detailed Description
The purpose of this study is to identify variations in the genome of HIV early after infection and following the development of AIDS to determine the location of escape mutations that might provide in...
Eligibility Criteria
Inclusion
- INCLUSION AND EXCLUSION CRITERIA:
- Sera and relevant clinical data from properly consented HIV positive seroconverters will be provided to the LGD for analysis. No available subjects will be excluded to maximize power. We will request an accrual ceiling of 100 participants.
Exclusion
Key Trial Info
Start Date :
September 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2007
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00340223
Start Date
September 1 2005
End Date
September 1 2007
Last Update
May 10 2012
Active Locations (7)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California, Los Angeles
Los Angeles, California, United States, 90095
2
Northwestern University
Chicago, Illinois, United States, 60611
3
Howard Brown Health Center
Chicago, Illinois, United States, 60613
4
John H. Stroger, Jr. Hospital of Cook County
Chicago, Illinois, United States